S233-1739 Screening compound: N-{[1-(cyclohexylmethyl)-2-oxo-octahydro-1H-cyclopenta[b]pyridin-4a-yl]methyl}-4-(methoxymethyl)-5-methyl-1,2-oxazole-3-carboxamide

S233-1739 Screening compound: N-{[1-(cyclohexylmethyl)-2-oxo-octahydro-1H-cyclopenta[b]pyridin-4a-yl]methyl}-4-(methoxymethyl)-5-methyl-1,2-oxazole-3-carboxamide
S233-1739 Screening compound: N-{[1-(cyclohexylmethyl)-2-oxo-octahydro-1H-cyclopenta[b]pyridin-4a-yl]methyl}-4-(methoxymethyl)-5-methyl-1,2-oxazole-3-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound S233-1739
N-{[1-(cyclohexylmethyl)-2-oxo-octahydro-1H-cyclopenta[b]pyridin-4a-yl]methyl}-4-(methoxymethyl)-5-methyl-1,2-oxazole-3-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S233-1739

Molecular Formula

C23H35N3O4 (C23 H35 N3 O4)

Compound Name

N-{[1-(cyclohexylmethyl)-2-oxo-octahydro-1H-cyclopenta[b]pyridin-4a-yl]methyl}-4-(methoxymethyl)-5-methyl-1,2-oxazole-3-carboxamide

IUPAC name

N-{[(4aS7aR)-1-(cyclohexylmethyl)-2-oxo-octahydro-1H-cyclopenta[b]pyridin-4a-yl]methyl}-4-(methoxymethyl)-5-methyl-12-oxazole-3-carboxamide

SMILES

Cc1c(COC)c(C(NC[C@](CCC2)(CC3)[C@@H]2N(CC2CCCCC2)C3=O)=O)no1

InChI

InChI=1S/C23H35N3O4/c1-16-18(14-29-2)21(25-30-16)22(28)24-15-23-11-6-9-19(23)26(20(27)10-12-23)13-17-7-4-3-5-8-17/h17,19H,3-15H2,1-2H3,(H,24,28)/t19-,23+/m1/s1

InChI Key

CHAGRBKJLRBSHY-XXBNENTESA-N

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

417.55

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.190

Distribution Coefficient, logD

3.190

Water Solubility, LogSw

-3.21

Polar Surface Area

71.791

Acid Dissociation Constant (pKa)

13.43

Base Dissociation Constant (pKb)

1.87

Number of Chiral Centers

2.00

Percent sp3 carbon bonding

78.26

S233-1739 in Drug Discovery

Included in Screening Libraries

3D-Diversity Natural-Product-Like Library (18102 compounds)

3D-Pharmacophore Based Diversity Library (49813 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Alpha-Helix Mimetics Library (25899 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
  • Mimetics
  • Mimetics
  • Cyclic compounds
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators

References: we are preparing a list of scientific research reports with S233-1739 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S233-1739?
Check Price and Availability of S233-1739, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S233-1739 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S233-1739
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S233-1739
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S233-1739 available by request